By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.
Li S, Dai W, Mo W, Li J, Feng J, Wu L, Liu T, Yu Q, Xu S, Wang W, Lu X, Zhang Q, Chen K, Xia Y, Lu J, Zhou Y, Fan X, Xu L, Guo C.
Li S, et al.
Int J Cancer. 2017 Dec 15;141(12):2571-2584. doi: 10.1002/ijc.31022. Epub 2017 Sep 14.
Int J Cancer. 2017.
PMID: 28857200
Free article.